Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...
Near-infrared spectroscopy (NIRS)-monitored cerebral oxygenation using the regional cerebral saturation (rScO 2) and the cerebral fractional tissue oxygen extraction (cFTOE), derived from rScO 2 and ...
7 Royal Surrey County Hospital NHS Foundation Trust and Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results